SEC Filing | Prestige Consumer Healthcare Inc.

View:

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

GTCR PARTNERS VIII L P

(Last)

(First)

(Middle)

C/O GTCR GOLDER RAUNER, LLC

SEARS TOWER #6100

(Street)

CHICAGO

60606-6402

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Prestige Brands Holdings, Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2008

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	08/19/2008		S		997⁽¹⁾	D	$10.03	736,164	D
Common Stock, par value $0.01 per share	08/19/2008		S		34⁽¹⁾	D	$10.13	736,130	D
Common Stock, par value $0.01 per share	08/19/2008		S		2,291⁽¹⁾	D	$10.05	733,839	D
Common Stock, par value $0.01 per share	08/19/2008		S		3,751⁽¹⁾	D	$10.04	730,088	D
Common Stock, par value $0.01 per share	08/19/2008		S		1,541⁽¹⁾	D	$10.06	728,547	D
Common Stock, par value $0.01 per share	08/19/2008		S		399⁽¹⁾	D	$9.98	728,148	D
Common Stock, par value $0.01 per share	08/19/2008		S		598⁽¹⁾	D	$9.95	727,550	D
Common Stock, par value $0.01 per share	08/19/2008		S		357⁽¹⁾	D	$9.92	727,193	D
Common Stock, par value $0.01 per share	08/19/2008		S		898⁽¹⁾	D	$9.93	726,295	D
Common Stock, par value $0.01 per share	08/19/2008		S		100⁽¹⁾	D	$9.89	726,195	D
Common Stock, par value $0.01 per share	08/19/2008		S		2,791⁽¹⁾	D	$9.88	723,404	D
Common Stock, par value $0.01 per share	08/19/2008		S		997⁽¹⁾	D	$9.87	722,407	D
Common Stock, par value $0.01 per share	08/19/2008		S		2,292⁽¹⁾	D	$9.9	720,115	D
Common Stock, par value $0.01 per share	08/19/2008		S		2,650⁽¹⁾	D	$9.84	717,465	D
Common Stock, par value $0.01 per share	08/19/2008		S		4,334⁽¹⁾	D	$9.83	713,131	D
Common Stock, par value $0.01 per share	08/19/2008		S		1,038⁽¹⁾	D	$9.82	712,093	D
Common Stock, par value $0.01 per share	08/19/2008		S		2,293⁽¹⁾	D	$9.86	709,800	D
Common Stock, par value $0.01 per share	08/19/2008		S		2,392⁽¹⁾	D	$9.85	707,408	D
Common Stock, par value $0.01 per share	08/19/2008		S		6,030⁽¹⁾	D	$9.81	701,378	D
Common Stock, par value $0.01 per share	08/19/2008		S		1,395⁽¹⁾	D	$9.8	699,983	D
Common Stock, par value $0.01 per share								11,122,046	I	See footnote⁽²⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

1. Name and Address of Reporting Person^*

GTCR PARTNERS VIII L P

(Last)

(First)

(Middle)

C/O GTCR GOLDER RAUNER, LLC

SEARS TOWER #6100

(Street)

CHICAGO

60606-6402

(City)

(State)

(Zip)

1. Name and Address of Reporting Person^*

GTCR GOLDER RAUNER II LLC

(Last)

(First)

(Middle)

C/O GTCR GOLDER RAUNER, LLC

SEARS TOWER #6100

(Street)

CHICAGO

60606-6402

(City)

(State)

(Zip)

Explanation of Responses:

1. Reflects shares received by GTCR Partners VIII, L.P. ("GTCR Partners VIII") as a result of pro rata distributions from GTCR Fund VIII, L.P. ("Fund VIII") and GTCR Fund VIII/B, L.P. ("Fund VIII/B") that were exempt from Section 16 of the Securities Exchange Act of 1934, as amended, pursuant to Rule 16a-13 promulgated thereunder.

2. Reflects 9,461,583 shares held directly by Fund VIII and 1,660,463 shares held directly by Fund VIII/B. GTCR Partners VIII is the general partner of Fund VIII and Fund VIII/B, and GTCR Golder Rauner II, L.L.C. ("GTCR II") is the general partner of GTCR Partners VIII. As such, GTCR Partners VIII and GTCR II may be deemed to be beneficial owners of the 11,122,046 shares reported in Table I. GTCR Partners VIII and GTCR II expressly disclaim beneficial ownership of such shares reported in Table I, except to the extent of their pecuniary interest therein. The filing of this form shall not be deemed an admission that GTCR Partners VIII or GTCR II is, for Section 16 purposes or otherwise, the beneficial owner of such shares, except to the extent of their pecuniary interest therein.

	/s/ Dennis M. Myers under a Power of Attorney	08/21/2008
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Primary IR Contact

Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

AST
6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449
help@astfinancial.com
https://www.astfinancial.com

Stay up to date with investor news, stock information and SEC filings.
Subscribe »